연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Division of Molecular Genetics
Peter Lichter has not added Biography.
If you are Peter Lichter and would like to personalize this page please email our Author Liaison for assistance.
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.
Acta neuropathologica Jul, 2014 | Pubmed ID: 24791927
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.
Cancer cell May, 2015 | Pubmed ID: 25965575
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
Oncotarget Sep, 2016 | Pubmed ID: 27556362
Spatial heterogeneity in medulloblastoma.
Nature genetics May, 2017 | Pubmed ID: 28394352
German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK)
Weijun Feng*,1,
Lena Herbst*,2,
Peter Lichter2,
Stefan M. Pfister3,4,5,
Hai-Kun Liu1,
Daisuke Kawauchi3,4
1Division of Molecular Neurogenetics, German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance,
2Division of Molecular Genetics, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK),
3, Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ),
4Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK),
5Department of Pediatric Hematology and Oncology, Heidelberg University Hospital
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유